Literature DB >> 11668313

Plasma levels of plasmin-antiplasmin-complexes are predictive for small abdominal aortic aneurysms expanding to operation-recommendable sizes.

J S Lindholt1, B Jørgensen, H Fasting, E W Henneberg.   

Abstract

OBJECTIVE: Three proteolytic systems seem involved in the aneurysmal degradation of the aortic wall. Plasmin is a common activator of the systems and could thus be predictive for the progression of abdominal aortic aneurysms (AAAs). METHODS AND MATERIALS: In 1994, 112 of 141 male patients with AAA diagnosed through population screening (defined as 3 cm or more) were interviewed and examined and had blood samples taken. One hundred twelve cases were scanned annually for 1 to 5 years (mean, 2.5 years) and referred for surgery if the AAA exceeded 5 cm in diameter. A random sample of 70 of the 112 cases had P-plasmin-antiplasmin-complexes (PAPs), P-plasminogen, and S-elastin-peptides (SEPs).
RESULTS: PAP was positively correlated with annual expansion rate (r = 0.39, 0.16-0.56), persisting after adjustment for initial AAA size, SEP, age, and smoking. However, PAP levels did not correlate with the initial AAA size or SEP. Furthermore, PAP levels were significantly predictive for cases expanding to operation-recommendable AAA sizes. Combined with the initial AAA size, both optimal sensitivity and specificity were 82%, increasing to 95% and 96%, respectively, excluding those lost to follow-up and accepting 2 mm of interobserver variation.
CONCLUSION: The progression of AAA is correlated with the PAP level, which seems to have a predictive value similar to the best serologic predictor known, serum-elastin-peptides.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11668313     DOI: 10.1067/mva.2001.119040

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  10 in total

Review 1.  Biomarkers of AAA progression. Part 1: extracellular matrix degeneration.

Authors:  Femke A M V I Hellenthal; Willem A Buurman; Will K W H Wodzig; Geert Willem H Schurink
Journal:  Nat Rev Cardiol       Date:  2009-05-26       Impact factor: 32.419

2.  Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms.

Authors:  Vincent Fontaine; Marie-Paule Jacob; Xavier Houard; Patrick Rossignol; Didier Plissonnier; Eduardo Angles-Cano; Jean-Baptiste Michel
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

3.  Management of small asymptomatic abdominal aortic aneurysms - a review.

Authors:  H Silaghi; A Branchereau; S Malikov; Aurel Andercou
Journal:  Int J Angiol       Date:  2007

4.  Renewal of mural thrombus releases plasma markers and is involved in aortic abdominal aneurysm evolution.

Authors:  Ziad Touat; Veronique Ollivier; Jianping Dai; Marie-Genevieve Huisse; Annie Bezeaud; Uriel Sebbag; Tony Palombi; Patrick Rossignol; Olivier Meilhac; Marie-Claude Guillin; Jean-Baptiste Michel
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

Review 5.  A role for proteoglycans in vascular disease.

Authors:  Thomas N Wight
Journal:  Matrix Biol       Date:  2018-02-27       Impact factor: 11.583

6.  Hyperglycemia modulates plasminogen activator inhibitor-1 expression and aortic diameter in experimental aortic aneurysm disease.

Authors:  Monica M Dua; Noriyuki Miyama; Junya Azuma; Geoffrey M Schultz; Mien Sho; John Morser; Ronald L Dalman
Journal:  Surgery       Date:  2010-06-19       Impact factor: 3.982

Review 7.  Circulating markers of abdominal aortic aneurysm presence and progression.

Authors:  Jonathan Golledge; Philip S Tsao; Ronald L Dalman; Paul E Norman
Journal:  Circulation       Date:  2008-12-02       Impact factor: 29.690

Review 8.  Novel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans.

Authors:  Jean-Baptiste Michel; José-Luis Martin-Ventura; Jesus Egido; Natzi Sakalihasan; Vladislav Treska; Jes Lindholt; Eric Allaire; Unnur Thorsteinsdottir; Gillian Cockerill; Jesper Swedenborg
Journal:  Cardiovasc Res       Date:  2010-10-30       Impact factor: 10.787

9.  Inhibition of plasmin-mediated TAFI activation may affect development but not progression of abdominal aortic aneurysms.

Authors:  Katherine Bridge; Charlotte Revill; Fraser Macrae; Marc Bailey; Nadira Yuldasheva; Stephen Wheatcroft; Roger Butlin; Richard Foster; D Julian Scott; Ann Gils; Robert Ariens
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

10.  Systematic Review of Circulating, Biomechanical, and Genetic Markers for the Prediction of Abdominal Aortic Aneurysm Growth and Rupture.

Authors:  Menno E Groeneveld; Jorn P Meekel; Sidney M Rubinstein; Lisanne R Merkestein; Geert Jan Tangelder; Willem Wisselink; Maarten Truijers; Kak Khee Yeung
Journal:  J Am Heart Assoc       Date:  2018-06-30       Impact factor: 5.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.